Search

Your search keyword '"Openshaw PJM"' showing total 142 results

Search Constraints

Start Over You searched for: Author "Openshaw PJM" Remove constraint Author: "Openshaw PJM"
142 results on '"Openshaw PJM"'

Search Results

1. Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses

2. The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection

3. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

4. International Pediatric COVID-19 Severity Over the Course of the Pandemic

5. Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: antibody dynamics and linkage to severity of COVID-19 in hospital inpatients

6. Procalcitonin is not a reliable biomarker of bacterial coinfection in people with coronavirus disease 2019 undergoing microbiological investigation at the time of hospital admission

7. Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study

9. Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

10. Mapping the human genetic architecture of COVID-19

11. Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19

12. Resilience of the respiratory microbiome in controlled adult RSV challenge study.

13. The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemic.

14. Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages

15. Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study : a prospective, multicentre cohort study

16. A prenylated dsRNA sensor protects against severe COVID-19

17. Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

18. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

19. COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

20. Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID-19: Analysis of the ISARIC CCP-UK Cohort

21. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study.

22. Obesity, chronic disease, age, and in-hospital mortality in patients with covid-19: analysis of ISARIC clinical characterisation protocol UK cohort

23. Short-term forecasts to inform the response to the Covid-19 epidemic in the UK

24. ISARIC COVID-19 Clinical Data Report: 4 October 2020

25. A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

26. Outcome of hospitalisation for COVID-19 in patients with interstitial lung disease: an international multicentre study

27. A new role for CXCL4 in RSV disease

28. Broad and strong memory CD4 (+) and CD8 (+) T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients

29. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

30. Tracheostomy in the COVID-19 era: global and multidisciplinary guidance

31. Progression of whole blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in patients with severe influenza

32. Alpha/Beta Interferon Receptor Signaling Amplifies Early Proinflammatory Cytokine Production in the Lung during Respiratory Syncytial Virus Infection

34. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)

36. Where is SARS now? The WHO and respective governments must be praised for their incisive and energetic leadership which has greatly limited the impact of SARS, but we can only guess what will happen next winter

40. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease.

41. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study

42. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

43. Serum and mucosal antibody-mediated protection and identification of asymptomatic respiratory syncytial virus infection in community-dwelling older adults in Europe.

44. Respiratory Syncytial Virus-related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort Study.

45. Antibody-mediated protection against respiratory syncytial virus in children.

46. Aging enhances pro-atrogenic gene expression and skeletal muscle loss following respiratory syncytial virus infection.

47. 1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study.

48. Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults.

49. Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19.

50. Changes in hospital mortality in patients with cancer during the COVID-19 pandemic (ISARIC-CCP-UK): a prospective, multicentre cohort study.

Catalog

Books, media, physical & digital resources